Ensign Peak Advisors, Inc

Position in ERAS — Erasca, Inc.

CIK 1454984 SALT LAKE CITY, UT

Position in ERAS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$8,101,698

+$7,995,198 QoQ

Shares Held

500,723

+901.4% QoQ

Ownership

0.161%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ensign Peak Advisors, Inc holds $1,156,213,147 across 116 Biotechnology names. ERAS ranks #37 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	215,165	$96,079,779
2	INSM	INSMED Inc	499,756	$81,720,101
3	ABVX	Abivax S.A.	631,838	$70,355,161
4	BBIO	BridgeBio Pharma, Inc.	836,552	$62,122,351
5	ARGX	Argenx SE	71,598	$52,284,439
6	RPRX	Royalty Pharma plc	932,650	$44,739,220
7	PTCT	Ptc Therapeutics, Inc.	582,318	$39,673,325
8	SRRK	Scholar Rock Holding Corp	717,253	$35,260,157

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,101,698	500,723	+901.4%	Shares	Sole	2026-05-13
2023-12-31	$106,500	50,000	0.0%	Shares	Sole	2024-02-14
2023-09-30	$98,500	50,000	0.0%	Shares	Sole	2023-11-13
2023-06-30	$138,000	50,000	0.0%	Shares	Sole	2023-08-14
2023-03-31	$150,500	50,000	0.0%	Shares	Sole	2023-05-15
2022-12-31	$215,500	50,000	-11.7%	Shares	Sole	2023-02-13
2022-09-30	$441,558	56,610	0.0%	Shares	Sole	2022-11-14
2022-06-30	$315,317	56,610	0.0%	Shares	Sole	2022-08-12
2022-03-31	$486,846	56,610	+13.2%	Shares	Sole	2022-05-16
2021-12-31	$779,000	50,000	0.0%	Shares	Sole	2022-02-11
2021-09-30	$1,061,000	50,000	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.